EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

SMARCB1 / INI1 ‐deficient intrathoracic neoplasm with rhabdoid/plasmacytoid cytomorphology in a patient with plasma cell myeloma: A case report

Kazuki Fujita, Keishi Mizuguchi, Tatsuya Mori, Tsubasa Shimoda, Kaori Sakano, Chie Shimaguchi, Ayumi Ito, Kaori Yoshimura, Maki Sakaguchi, Tatsuya Imi, Hiroko Ikeda iD

Diagnostic Cytopathology · 2023-10 · 51 (10)

DOI: 10.1002/dc.25197 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Diagnostic Cytopathology, online erschienen am 20.07.2023. Verfasst von Kazuki Fujita und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan. Hauptthemen laut MEDLINE: Multiple Myeloma, Rhabdoid Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SMARCB1 (INI1) is one of the switch/sucrose nonfermentable (SWI/SNF) complexes whose loss is associated with several tumors. SMARCB1 (INI1)‐deficient intrathoracic neoplasms are extremely rare and known to be highly malignant and lethal. This report presents the case of a patient diagnosed with SMARCB1 (INI1)‐deficient intrathoracic neoplasm during chemotherapy for plasma cell myeloma. A 77‐year‐old male patient complained of cough, bloody sputum, and fever with an enlarged right lung mass and pleural effusion. His cytological examination revealed undifferentiated epithelioid and rhabdoid/plasmacytoid cells with bi‐ or multinucleation, vacuolization, mitosis, and pleomorphism. However, it was difficult to distinguish the relapse of plasma cell myeloma as atypical plasmacytoid cells were detected. Immunohistochemically, the neoplastic cells showed a loss of SMARCB1 (INI1) expression in the cell block of pleural fluid and in the right lung of the autopsy specimen. Further, the patient was diagnosed with SMARCB1 (INI1)‐deficient intrathoracic neoplasm of the right lung based on histological and autopsy findings. To the best of our knowledge, this is the first report of cytomorphology in a SMARCB1 (INI1)‐deficient intrathoracic neoplasm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaRhabdoid TumorMaleHumansAgedNeoplasm Recurrence, LocalSMARCB1 ProteinBiomarkers, Tumor

Stichwörter der Autor:innen

INI1SMARCB1myelomapleural effusionrhabdoid/plasmacytoid

Substanzen

SMARCB1 ProteinBiomarkers, TumorSMARCB1 protein, human

Autor:innen und Institutionen

  • Department of Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan.
  • Department of Hematology, Kanazawa University Hospital, Kanazawa, Japan.

ORCID-Profile: Hiroko Ikeda

Zitieren

APA

Fujita, K., Mizuguchi, K., Mori, T., Shimoda, T., Sakano, K., Shimaguchi, C., Ito, A., Yoshimura, K., Sakaguchi, M., Imi, T., & Ikeda, H. (2023). SMARCB1 / INI1 ‐deficient intrathoracic neoplasm with rhabdoid/plasmacytoid cytomorphology in a patient with plasma cell myeloma: A case report. Diagnostic Cytopathology, 51(10). https://doi.org/10.1002/dc.25197

Vancouver

Fujita K, Mizuguchi K, Mori T, Shimoda T, Sakano K, Shimaguchi C, et al. SMARCB1 / INI1 ‐deficient intrathoracic neoplasm with rhabdoid/plasmacytoid cytomorphology in a patient with plasma cell myeloma: A case report. Diagnostic Cytopathology. 2023;51(10). doi:10.1002/dc.25197

BibTeX
@article{Fujita2023,
  author = {Fujita, Kazuki and Mizuguchi, Keishi and Mori, Tatsuya and Shimoda, Tsubasa and Sakano, Kaori and Shimaguchi, Chie and Ito, Ayumi and Yoshimura, Kaori and Sakaguchi, Maki and Imi, Tatsuya and Ikeda, Hiroko},
  title = {SMARCB1 / INI1 ‐deficient intrathoracic neoplasm with rhabdoid/plasmacytoid cytomorphology in a patient with plasma cell myeloma: A case report},
  journal = {Diagnostic Cytopathology},
  year = {2023},
  volume = {51},
  number = {10},
  doi = {10.1002/dc.25197}
}
Kostenlos starten →